# Pharmacokinetics of Delgocitinib 20 mg/g Cream in Subjects With Chronic Hand Eczema

> **NCT05486117** · PHASE1 · COMPLETED · sponsor: **LEO Pharma** · enrollment: 15 (actual)

## Conditions studied

- Chronic Hand Eczema

## Interventions

- **DRUG:** Delgocitinib

## Key facts

- **NCT ID:** NCT05486117
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-06
- **Primary completion:** 2022-11-22
- **Final completion:** 2022-11-22
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2025-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05486117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05486117, "Pharmacokinetics of Delgocitinib 20 mg/g Cream in Subjects With Chronic Hand Eczema". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05486117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*